Late multiple organ surge in interferon-regulated target genes characterizes staphylococcal enterotoxin B lethality

PLoS One. 2014 Feb 13;9(2):e88756. doi: 10.1371/journal.pone.0088756. eCollection 2014.

Abstract

Background: Bacterial superantigens are virulence factors that cause toxic shock syndrome. Here, the genome-wide, temporal response of mice to lethal intranasal staphylococcal enterotoxin B (SEB) challenge was investigated in six tissues.

Results: The earliest responses and largest number of affected genes occurred in peripheral blood mononuclear cells (PBMC), spleen, and lung tissues with the highest content of both T-cells and monocyte/macrophages, the direct cellular targets of SEB. In contrast, the response of liver, kidney, and heart was delayed and involved fewer genes, but revealed a dominant genetic program that was seen in all 6 tissues. Many of the 85 uniquely annotated transcripts participating in this shared genomic response have not been previously linked to SEB. Nine of the 85 genes were subsequently confirmed by RT-PCR in every tissue/organ at 24 h. These 85 transcripts, up-regulated in all tissues, annotated to the interferon (IFN)/antiviral-response and included genes belonging to the DNA/RNA sensing system, DNA damage repair, the immunoproteasome, and the ER/metabolic stress-response and apoptosis pathways. Overall, this shared program was identified as a type I and II interferon (IFN)-response and the promoters of these genes were highly enriched for IFN regulatory matrices. Several genes whose secreted products induce the IFN pathway were up-regulated at early time points in PBMCs, spleen, and/or lung. Furthermore, IFN regulatory factors including Irf1, Irf7 and Irf8, and Zbp1, a DNA sensor/transcription factor that can directly elicit an IFN innate immune response, participated in this host-wide SEB signature.

Conclusion: Global gene-expression changes across multiple organs implicated a host-wide IFN-response in SEB-induced death. Therapies aimed at IFN-associated innate immunity may improve outcome in toxic shock syndromes.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Administration, Intranasal
  • Animals
  • Enterotoxins
  • Gene Expression Regulation
  • Genome-Wide Association Study
  • Immunity, Innate / genetics*
  • Injections, Intraperitoneal
  • Interferon Regulatory Factors / genetics*
  • Interferon Regulatory Factors / immunology
  • Kidney / immunology
  • Kidney / pathology
  • Leukocytes, Mononuclear / immunology
  • Leukocytes, Mononuclear / pathology
  • Liver / immunology
  • Liver / pathology
  • Lung / immunology
  • Lung / pathology
  • Male
  • Mice
  • Myocardium / immunology
  • Myocardium / pathology
  • Promoter Regions, Genetic
  • Shock, Septic / chemically induced
  • Shock, Septic / genetics*
  • Shock, Septic / immunology
  • Shock, Septic / mortality
  • Spleen / immunology
  • Spleen / pathology
  • Survival Analysis
  • Transcriptome / immunology*

Substances

  • Enterotoxins
  • Interferon Regulatory Factors
  • enterotoxin B, staphylococcal

Grants and funding

This research was entirely funded by The Defense Threat Reduction Agency (#DTRA 3.10035) and the Intramural Research Program of the Critical Care Medicine Department, NIH Clinical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.